Basepaws
Basepaws is a US-based pet genetics company founded in 2017 that sells at-home DNA testing kits for cats and dogs using Next-Generation Sequencing technology to provide breed identification, health risk screening, and oral microbiome analysis to individual pet parents, operating as a wholly-owned subsidiary of Zoetis since 2022.
- Company typePrivate
- Founded2017
- HeadquartersEl Segundo, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Basepaws does
Basepaws is a US-based pet genetics company founded in 2017 that develops and sells at-home DNA testing kits for cats and dogs, providing breed identification, genetic health risk screening, trait analysis, and oral microbiome assessment. The company's core technology uses Next-Generation Sequencing (NGS), including a premium Whole Genome Sequencing tier that decodes 100% of the cat genome at 15x coverage with raw FASTQ and VCF data outputs. The proprietary Feline Oral Microbiome Analysis screens 600+ microbes for signatures of periodontal disease, tooth resorption, and halitosis. Basepaws operates a direct-to-consumer e-commerce model selling one-time test kits priced from $79.99 to $499 through basepaws.com, supplemented by a community-led citizen science program that builds the company's proprietary feline genomic and oral microbiome database.
In 2022, Basepaws was acquired by Zoetis, the world's leading animal health company, for at least $50 million, with the company now operating as a wholly-owned subsidiary and leveraging Zoetis's veterinary distribution, R&D, and precision medicine infrastructure. The customer base is highly fragmented across individual pet parents, with secondary reach into veterinary professionals via a dedicated vet portal. Pricing ranges from $79.99 for the Breed + Health Dog DNA Test to $499 for Whole Genome Sequencing, with optional pay-in-4 and affirm financing for higher-priced orders. The company maintains 11-50 employees with headquarters in El Segundo (website presence) and a legal address at Zoetis c/o Basepaws in Kalamazoo, Michigan, and operates across North America with international shipping available.
Basepaws firmographics
Firmographics- Name
- Basepaws
- Legal name
- Basepaws Inc.
- Website
- https://basepaws.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- Basepaws is a US-based pet genetics company founded in 2017 that sells at-home DNA testing kits for cats and dogs using Next-Generation Sequencing technology to provide breed identification, health risk screening, and oral microbiome analysis to individual pet parents, operating as a wholly-owned subsidiary of Zoetis since 2022.
- Ownership category
- akta.pro rank
Basepaws industry classification
Industry- Product category
- Pet Genetic Testing
- NAICS
- Medical Laboratories (621511)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Molecular & Genetic Testing (Breed, Hereditary Disease, Oncology) (HLAMADAE)
- akta.pro secondary industries
- Laboratory & Point-of-Care Diagnostic Devices (Analyzers, Test Kits, Microscopy) (HLAMAFAI), Veterinary Microbiology & Infectious Disease Testing (Culture/PCR/Serology) (HLAMADAC)
Keywords
Where Basepaws is headquartered
LocationHeadquarters
- HQ city
- El Segundo
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Basepaws business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Revenue model
- Direct-to-Consumer DNA Test Kits: One-time product sales of at-home pet DNA testing kits sold directly to consumers through e-commerce. Products include Breed + Health Cat DNA Test, Dog DNA Test, Oral Health Test for Cats, and Whole Genome Sequencing. Revenue is generated per test kit with no subscription requirement, though Whole Genome Sequencing includes free lifetime report updates.
- Optional Financing: Pay-in-4 interest-free installments offered for orders over $50, and monthly payment plans through third-party financing (affirm). This extends accessibility to higher-priced products like Whole Genome Sequencing at $499.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Breed + Health Cat DNA Test - $99.99 (regularly $159.00) |
| One time/ perpetual license | Pay-as-you-go | Breed + Health Dog DNA Test - $79.99 (regularly $149.00) |
| One time/ perpetual license | Pay-as-you-go | Whole Genome Sequencing for Cats - $499.00 |
| One time/ perpetual license | Pay-as-you-go | Oral Health Test for Cats - $99.00 |
Go-to-market motion3 records
Distribution channels2 records
Marketing channels5 records
Basepaws product offering
Product offeringCore offering
Basepaws sells at-home DNA testing kits for cats and dogs that use cheek-swab sample collection and Next-Generation Sequencing laboratory analysis to deliver personalized digital reports covering breed composition, genetic health risk markers, trait markers, and oral microbiome disease signatures. Its product line includes the Breed + Health Cat DNA Test, Breed + Health Dog DNA Test, a standalone Oral Health Test for Cats, and a premium Whole Genome Sequencing product for cats.
Product overview
Basepaws offers an integrated portfolio of at-home pet health genetic testing products for cats and dogs. The core offerings include the Breed + Health DNA Tests (for both cats and dogs) which provide breed identification, genetic health screening, and trait analysis. The Cat DNA Test screens for 21 cat breeds, 64 health markers, and 50 trait markers with an included oral health report; the Dog DNA Test covers 330+ breeds, 280+ health markers, and 30+ trait markers. Premium add-ons include the Oral Health Test for Cats (standalone oral microbiome screening) and Whole Genome Sequencing for Cats (comprehensive 100% genome decoding with raw data files and lifetime updates). All tests use cheek swab sample collection with results delivered digitally within 4-12 weeks.
Differentiator
Problem solved
Functional benefit
Products and services
- Breed + Health Cat DNA Test At-home DNA test for cats that identifies 21 cat breeds, screens for 64 genetic health markers and 50 genetic trait markers, includes an oral health report and blood type, with digital results delivered in 4-6 weeks.
- Breed + Health Dog DNA Test At-home DNA test for dogs providing breed composition analysis across 330+ breeds, screening for 280+ health markers and 30+ trait markers using Next-Generation Sequencing, with results delivered digitally in 4-6 weeks.
- Oral Health Test for Cats Standalone at-home oral microbiome test for cats that screens 600+ microbes for risk signatures associated with periodontal disease, tooth resorption, and halitosis, and provides risk scores plus personalized clinical care and at-home care recommendations.
- Whole Genome Sequencing for Cats Premium DNA sequencing service decoding 100% of a cat's genome at 15x coverage, producing 10,000x more data than standard DNA microarrays; includes everything in the Breed + Health test plus raw FASTQ/VCF data files and free lifetime report updates, with results in 9-12 weeks.
- Dog Fitness Program Free 3-part email-based fitness program that delivers personalized exercise plans tailored to a dog's DNA profile, breed-specific workouts, and guidance on how genetics influence exercise requirements.
Quantifiable outcome
- 70% of adult cats have dental health problems - early detection enables proactive intervention
- +2 more outcomes
Companies that use Basepaws
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
Basepaws technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature6 records
Basepaws partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights5 records
Basepaws competitors and assessment
Company assessmentDirect peers
- Embark Veterinary: Embark is the leading direct-to-consumer dog and cat DNA testing company, using genotyping and breed identification. It is the most direct competitor to Basepaws in the pet genetic testing space, with overlapping product offerings (breed, health, and trait tests) and similar NGS-based technology approach.
- Wisdom Panel: Wisdom Panel, owned by Mars Petcare, is a major pet genetic testing brand offering breed identification and health screening for both dogs and cats. It is one of the largest competitors in the DTC pet DNA market with broad retail distribution through pet stores and veterinary channels.
- DNA My Dog: DNA My Dog offers breed identification and genetic testing for dogs at lower price points. While less scientifically comprehensive than Basepaws' offerings, it competes for price-sensitive pet parents in the same DTC genetic testing category.
- Orivet Genetic Pet Care: Orivet provides genetic testing for dogs and cats with a focus on breed identification, health screening, and personalized wellness plans. It serves both pet owners and veterinary professionals, overlapping with Basepaws' vet and consumer channels.
- Paw Print Genetics: Paw Print Genetics specializes in genetic testing for hereditary diseases in dogs and cats. It is more clinically-oriented than Basepaws but overlaps in the disease screening and genetic health marker testing space.
Broad incumbents
- Zoetis: Zoetis is the parent company of Basepaws and the world's leading animal health company. It offers diagnostics, vaccines, and pharmaceuticals across the veterinary sector, providing Basepaws access to a global distribution network and clinical research infrastructure.
- IDEXX Laboratories: IDEXX is a dominant veterinary diagnostics company offering in-clinic lab tests, reference lab services, and imaging for companion animals. As a broad incumbent, it competes indirectly with Basepaws in the pet health diagnostics space and represents a potential acquirer or strategic partner.
- Antech Diagnostics: Antech Diagnostics (owned by Mars) provides veterinary reference lab services, imaging, and diagnostic testing across the U.S. It is a broad incumbent in veterinary diagnostics with deeper vet-channel distribution than Basepaws.
Emerging players
- PetDx: PetDx focuses on liquid biopsy and genomic testing for cancer detection in dogs. While focused on oncology rather than breed/trait testing, it overlaps with Basepaws in applying NGS technology to companion animal health.
Others
- Royal Canin (Mars Petcare): Royal Canin, owned by Mars Petcare, produces breed-specific and health-targeted pet foods. Basepaws' data could be integrated into breed-specific nutrition products via its parent Zoetis, making Royal Canin a comparable thematically adjacent player in personalized pet nutrition.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Basepaws social profiles
Digital presenceBasepaws financial estimates
Financial estimateRevenue estimate
Valuation estimate
Basepaws leadership team
Management profileNumber of profiles
Profiles6 records
Basepaws funding detail
Funding detailFunding overview
Funding rounds5 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Basepaws M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Basepaws
What does Basepaws do?
Basepaws sells at-home DNA testing kits for cats and dogs that use cheek-swab sample collection and Next-Generation Sequencing laboratory analysis to deliver personalized digital reports covering breed composition, genetic health risk markers, trait markers, and oral microbiome disease signatures. Its product line includes the Breed + Health Cat DNA Test, Breed + Health Dog DNA Test, a standalone Oral Health Test for Cats, and a premium Whole Genome Sequencing product for cats.
Is Basepaws a public or private company?
Basepaws is a private company. It is classified as corporate owned and is currently acquired.
When was Basepaws founded?
Basepaws was founded in 2017. It employs 11 to 50 people.
Where is Basepaws based?
Basepaws is headquartered in El Segundo, United States, in the North America region.
How does Basepaws make money?
Two revenue lines are on record. Direct-to-Consumer DNA Test Kits are the primary driver. The others are optional Financing.
Who are Basepaws's main competitors?
Direct peers on record are Embark Veterinary, Wisdom Panel, DNA My Dog, Orivet Genetic Pet Care and Paw Print Genetics. Broad incumbents are Zoetis, IDEXX Laboratories and Antech Diagnostics. PetDx is listed as an emerging player. Royal Canin (Mars Petcare) is listed as an others.
Does Basepaws have an API?
No public API is recorded for Basepaws.
What industry is Basepaws in?
Basepaws's product category is Pet Genetic Testing. Its primary akta.pro industry code is HLAMADAE, Molecular & Genetic Testing (Breed, Hereditary Disease, Oncology), with a secondary code of HLAMAFAI, Laboratory & Point-of-Care Diagnostic Devices (Analyzers, Test Kits, Microscopy). Its NAICS code is 621511 and its SIC code is 2835.